Treatment With Propranolol for Infantile Hemangioma in 13 Taiwanese Newborns and Young Infants
Hemangioma in infants has a benign self-limited course, but the 10% of cases with complications need further treatment. Successful treatment with propranolol in western countries has been reported over the past few years. We evaluated the efficacy of propranolol for treating infantile hemangioma in...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2012-04-01
|
| Series: | Pediatrics and Neonatology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1875957212000113 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850241220680351744 |
|---|---|
| author | Teng-Chin Hsu Jiaan-Der Wang Chao-Huei Chen Te-Kau Chang Teh-Ming Wang Chia-Man Chou Heng-Kuei Lin |
| author_facet | Teng-Chin Hsu Jiaan-Der Wang Chao-Huei Chen Te-Kau Chang Teh-Ming Wang Chia-Man Chou Heng-Kuei Lin |
| author_sort | Teng-Chin Hsu |
| collection | DOAJ |
| description | Hemangioma in infants has a benign self-limited course, but the 10% of cases with complications need further treatment. Successful treatment with propranolol in western countries has been reported over the past few years. We evaluated the efficacy of propranolol for treating infantile hemangioma in Taiwanese newborns and young infants.
Methods: Patients below 1 year of age treated with propanolol between November 2009 and March 2011 were enrolled. Demographic data, clinical features, imaging findings, treatment regimens of propranolol, and outcome were investigated.
Results: Thirteen patients were treated with propranolol at a dose of 2–3 mg/kg/day. Seven (53.8%) patients had solitary hemangioma and six had multiple ones. The indications for treatment were risk of local event in nine patients, functional risk in four, local complication in one, and life-threatening complication in one. The median age for starting propranolol was 4 months (range: 1–11 months). Responses to propranolol, such as decolorization, regression in tumor size, or improvement of hemangioma-associated complications were observed in all patients within 1–2 weeks after treatment. Propranolol-associated adverse effects occurred in two patients. One infant had occasional tachypnea, and the other had occasional pale-looking appearance. The symptoms resolved after dosage tapering.
Conclusion: Propranolol may be a promising therapeutic modality for infantile hemangioma. Therapeutic strategies are needed to evaluate the optimal treatment protocol and long-term adverse effects. |
| format | Article |
| id | doaj-art-c8996a16dec140eeb7e8f37fb7166d0e |
| institution | OA Journals |
| issn | 1875-9572 |
| language | English |
| publishDate | 2012-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Pediatrics and Neonatology |
| spelling | doaj-art-c8996a16dec140eeb7e8f37fb7166d0e2025-08-20T02:00:39ZengElsevierPediatrics and Neonatology1875-95722012-04-0153212513210.1016/j.pedneo.2012.01.010Treatment With Propranolol for Infantile Hemangioma in 13 Taiwanese Newborns and Young InfantsTeng-Chin Hsu0Jiaan-Der Wang1Chao-Huei Chen2Te-Kau Chang3Teh-Ming Wang4Chia-Man Chou5Heng-Kuei Lin6Department of Pediatrics, Chiayi Branch, Taichung Veterans General Hospital, Chiayi, TaiwanDepartment of Pediatrics, Taichung Veterans General Hospital, Taichung, TaiwanDepartment of Pediatrics, Taichung Veterans General Hospital, Taichung, TaiwanDepartment of Pediatrics, Taichung Veterans General Hospital, Taichung, TaiwanDepartment of Pediatrics, Taichung Veterans General Hospital, Taichung, TaiwanDivision of Pediatric Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung, TaiwanDepartment of Pediatrics, Taichung Veterans General Hospital, Taichung, TaiwanHemangioma in infants has a benign self-limited course, but the 10% of cases with complications need further treatment. Successful treatment with propranolol in western countries has been reported over the past few years. We evaluated the efficacy of propranolol for treating infantile hemangioma in Taiwanese newborns and young infants. Methods: Patients below 1 year of age treated with propanolol between November 2009 and March 2011 were enrolled. Demographic data, clinical features, imaging findings, treatment regimens of propranolol, and outcome were investigated. Results: Thirteen patients were treated with propranolol at a dose of 2–3 mg/kg/day. Seven (53.8%) patients had solitary hemangioma and six had multiple ones. The indications for treatment were risk of local event in nine patients, functional risk in four, local complication in one, and life-threatening complication in one. The median age for starting propranolol was 4 months (range: 1–11 months). Responses to propranolol, such as decolorization, regression in tumor size, or improvement of hemangioma-associated complications were observed in all patients within 1–2 weeks after treatment. Propranolol-associated adverse effects occurred in two patients. One infant had occasional tachypnea, and the other had occasional pale-looking appearance. The symptoms resolved after dosage tapering. Conclusion: Propranolol may be a promising therapeutic modality for infantile hemangioma. Therapeutic strategies are needed to evaluate the optimal treatment protocol and long-term adverse effects.http://www.sciencedirect.com/science/article/pii/S1875957212000113hemangiomainfantpropranolol |
| spellingShingle | Teng-Chin Hsu Jiaan-Der Wang Chao-Huei Chen Te-Kau Chang Teh-Ming Wang Chia-Man Chou Heng-Kuei Lin Treatment With Propranolol for Infantile Hemangioma in 13 Taiwanese Newborns and Young Infants Pediatrics and Neonatology hemangioma infant propranolol |
| title | Treatment With Propranolol for Infantile Hemangioma in 13 Taiwanese Newborns and Young Infants |
| title_full | Treatment With Propranolol for Infantile Hemangioma in 13 Taiwanese Newborns and Young Infants |
| title_fullStr | Treatment With Propranolol for Infantile Hemangioma in 13 Taiwanese Newborns and Young Infants |
| title_full_unstemmed | Treatment With Propranolol for Infantile Hemangioma in 13 Taiwanese Newborns and Young Infants |
| title_short | Treatment With Propranolol for Infantile Hemangioma in 13 Taiwanese Newborns and Young Infants |
| title_sort | treatment with propranolol for infantile hemangioma in 13 taiwanese newborns and young infants |
| topic | hemangioma infant propranolol |
| url | http://www.sciencedirect.com/science/article/pii/S1875957212000113 |
| work_keys_str_mv | AT tengchinhsu treatmentwithpropranololforinfantilehemangiomain13taiwanesenewbornsandyounginfants AT jiaanderwang treatmentwithpropranololforinfantilehemangiomain13taiwanesenewbornsandyounginfants AT chaohueichen treatmentwithpropranololforinfantilehemangiomain13taiwanesenewbornsandyounginfants AT tekauchang treatmentwithpropranololforinfantilehemangiomain13taiwanesenewbornsandyounginfants AT tehmingwang treatmentwithpropranololforinfantilehemangiomain13taiwanesenewbornsandyounginfants AT chiamanchou treatmentwithpropranololforinfantilehemangiomain13taiwanesenewbornsandyounginfants AT hengkueilin treatmentwithpropranololforinfantilehemangiomain13taiwanesenewbornsandyounginfants |